Dana A. Zakalik

Dana A. Zakalik

Medical Genetics | Oncology

3577 West 13 Mile Road
Suite 140
Royal Oak, MI 48073

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 28, 2026

Lynch syndrome integrative epidemiology and genetics (LINEAGE): rationale for cohort design.

Lynch syndrome integrative epidemiology and genetics (LINEAGE): rationale for cohort design.

Journal: Familial cancer

Published: December 11, 2025

The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1.

The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1.

Journal: Current oncology (Toronto, Ont.)

Published: October 20, 2025

Endometriosis in Carriers of a Pathogenic Variant in BRCA1 or BRCA2: A Descriptive Analysis of a Large Multicentral BRCA Carrier Cohort.

Endometriosis in Carriers of a Pathogenic Variant in BRCA1 or BRCA2: A Descriptive Analysis of a Large Multicentral BRCA Carrier Cohort.

Journal: Current oncology (Toronto, Ont.)

Published: October 20, 2025

Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2.

Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2.

Journal: Journal of the National Cancer Institute

Published: July 16, 2025

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.

Journal: Gynecologic oncology

Published: July 07, 2025

Case Report: Androgen receptor-positive, locoregionally advanced breast cancer in a transgender man and an update on breast cancer management in a gender-diverse patient population.

Case Report: Androgen receptor-positive, locoregionally advanced breast cancer in a transgender man and an update on breast cancer management in a gender-diverse patient population.

Journal: Frontiers in oncology

Published: June 25, 2025

Incidence of endometrial cancer in BRCA mutation carriers.

Incidence of endometrial cancer in BRCA mutation carriers.

Journal: Gynecologic oncology

Published: May 15, 2024

The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation.

The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation.

Journal: Cancer

Published: May 06, 2024

The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration.

The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration.

Journal: Cancer

Published: March 06, 2024

Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations.

Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations.

Journal: JAMA oncology

Published: February 29, 2024

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.

Journal: JAMA oncology

Published: February 29, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026